当前位置: 首页 >> 检索结果
共有 367 条符合本次的查询结果, 用时 8.108832 秒

321. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies.

作者: Alexandra D Frolkis.;Jonathan Dykeman.;María E Negrón.;Jennifer Debruyn.;Nathalie Jette.;Kirsten M Fiest.;Talia Frolkis.;Herman W Barkema.;Kevin P Rioux.;Remo Panaccione.;Subrata Ghosh.;Samuel Wiebe.;Gilaad G Kaplan.
来源: Gastroenterology. 2013年145卷5期996-1006页
The inflammatory bowel diseases (IBDs) are chronic diseases that often require surgery. However, the risk of requirement of surgery over time has not been well characterized. We performed a systematic review and meta-analysis to establish the cumulative risk of surgery among patients with IBD and evaluated how this risk has changed over time.

322. Role of vitamin K2 in preventing the recurrence of hepatocellular carcinoma after curative treatment: a meta-analysis of randomized controlled trials.

作者: Irbaz Bin Riaz.;Haris Riaz.;Talha Riaz.;Sophia Rahman.;Muhammad Amir.;Maaz B Badshah.;Abdul Nafey Kazi.
来源: BMC Gastroenterol. 2012年12卷170页
Hepatocellular cancer is notorious for recurrence even after curative therapy. High recurrence determines the long term prognosis of the patients. Vitamin K2 has been tested in trials for its effect on prevention of recurrence and improving survival. The results are inconclusive from individual trials and in our knowledge no systematic review which entirely focuses on Vitamin K2 as a chemo preventive agent is available to date. This review is an attempt to pool all the existing trials together and update the existing knowledge on the topic.

323. Efficacy of conservative treatment, without necrosectomy, for infected pancreatic necrosis: a systematic review and meta-analysis.

作者: Venigalla Pratap Mouli.;Vishnubhatla Sreenivas.;Pramod Kumar Garg.
来源: Gastroenterology. 2013年144卷2期333-340.e2页
Conservative treatment (intensive care, a combination of antimicrobial agents, and nutritional support, with or without drainage of the infected fluid) has recently been shown to be effective for patients with infected pancreatic necrosis (IPN), but the data from individual studies are not robust enough to recommend it as the standard of care. We performed a systematic review and meta-analysis of studies related to primary conservative management for IPN.

324. Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis.

作者: Siddharth Singh.;Preet Paul Singh.;Abha Goyal Singh.;Mohammad Hassan Murad.;William Sanchez.
来源: Gastroenterology. 2013年144卷2期323-332页
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide. Several studies have shown that statins could have chemopreventive effects on HCC. We performed a systematic review and meta-analysis of studies that evaluated the effects of statins on the risk of HCC.

325. Polymorphisms in ERCC1, GSTs, TS and MTHFR predict clinical outcomes of gastric cancer patients treated with platinum/5-Fu-based chemotherapy: a systematic review.

作者: Zhen Wang.;Jun-qiang Chen.;Jin-lu Liu.;Xin-gan Qin.;Yuan Huang.
来源: BMC Gastroenterol. 2012年12卷137页
Despite genetic polymorphism in response to platinum/5-Fu chemotherapy in gastric cancer (GC) has been studied, data reported so far are conflicting and critical consideration is needed before translation to the treatment of GC.

326. Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis.

作者: Yannick Bacq.;Loïc Sentilhes.;Humberto B Reyes.;Anna Glantz.;Jurate Kondrackiene.;Tomas Binder.;Pier Luigi Nicastri.;Anna Locatelli.;Annarosa Floreani.;Ismael Hernandez.;Vincent Di Martino.
来源: Gastroenterology. 2012年143卷6期1492-501页
We performed a meta-analysis to evaluate the effects of ursodeoxycholic acid (UDCA) on pruritus, liver test results, and outcomes of babies born to women with intrahepatic cholestasis of pregnancy (ICP).

327. The relationship between urban environment and the inflammatory bowel diseases: a systematic review and meta-analysis.

作者: Ing Shian Soon.;Natalie A Molodecky.;Doreen M Rabi.;William A Ghali.;Herman W Barkema.;Gilaad G Kaplan.
来源: BMC Gastroenterol. 2012年12卷51页
The objective of this study was to conduct a systematic review with meta-analysis of studies assessing the association between living in an urban environment and the development of the Crohn's disease (CD) or ulcerative colitis (UC).

328. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review.

作者: Natalie A Molodecky.;Ing Shian Soon.;Doreen M Rabi.;William A Ghali.;Mollie Ferris.;Greg Chernoff.;Eric I Benchimol.;Remo Panaccione.;Subrata Ghosh.;Herman W Barkema.;Gilaad G Kaplan.
来源: Gastroenterology. 2012年142卷1期46-54.e42; quiz e30页
We conducted a systematic review to determine changes in the worldwide incidence and prevalence of ulcerative colitis (UC) and Crohn's disease (CD) in different regions and with time.

329. Narrow-band imaging does not improve detection of colorectal polyps when compared to conventional colonoscopy: a randomized controlled trial and meta-analysis of published studies.

作者: Luis C Sabbagh.;Ludovic Reveiz.;Diego Aponte.;Sylvia de Aguiar.
来源: BMC Gastroenterol. 2011年11卷100页
A colonoscopy may frequently miss polyps and cancers. A number of techniques have emerged to improve visualization and to reduce the rate of adenoma miss.

330. Most bowel cancer symptoms do not indicate colorectal cancer and polyps: a systematic review.

作者: Barbara-Ann Adelstein.;Petra Macaskill.;Siew F Chan.;Peter H Katelaris.;Les Irwig.
来源: BMC Gastroenterol. 2011年11卷65页
Bowel symptoms are often considered an indication to perform colonoscopy to identify or rule out colorectal cancer or precancerous polyps. Investigation of bowel symptoms for this purpose is recommended by numerous clinical guidelines. However, the evidence for this practice is unclear. The objective of this study is to systematically review the evidence about the association between bowel symptoms and colorectal cancer or polyps.

331. Imaging in assessing hepatic and peritoneal metastases of gastric cancer: a systematic review.

作者: Zhen Wang.;Jun-Qiang Chen.
来源: BMC Gastroenterol. 2011年11卷19页
Hepatic and peritoneal metastases of gastric cancer are operation contraindications. Systematic review to provide an overview of imaging in predicting the status of liver and peritoneum pre-therapeutically is essential.

332. Helicobacter pylori infection and circulating ghrelin levels - a systematic review.

作者: Chidi V Nweneka.;Andrew M Prentice.
来源: BMC Gastroenterol. 2011年11卷7页
The nature of the association between ghrelin, an orexigenic hormone produced mainly in the stomach, and Helicobacter pylori (H pylori), a bacterium that colonises the stomach, is still controversial. We examined available evidence to determine whether an association exists between the two; and if one exists, in what direction.

333. Association between HLA-DRB1 alleles polymorphism and hepatocellular carcinoma: a meta-analysis.

作者: Zhong-Hua Lin.;Yong-Ning Xin.;Quan-Jiang Dong.;Qing Wang.;Xiang-Jun Jiang.;Shu-Hui Zhan.;Ying Sun.;Shi-Ying Xuan.
来源: BMC Gastroenterol. 2010年10卷145页
HLA-DRB1 allele polymorphisms have been reported to be associated with hepatocellular carcinoma susceptibility, but the results of these previous studies have been inconsistent. The purpose of the present study was to explore whether specific HLA-DRB1 alleles (DRB1*07, DRB1*12, DRB1*15) confer susceptibility to hepatocellular carcinoma.

334. Endoscopic treatments for Barrett's esophagus: a systematic review of safety and effectiveness compared to esophagectomy.

作者: Devidas Menon.;Tania Stafinski.;Heng Wu.;Darren Lau.;Clarence Wong.
来源: BMC Gastroenterol. 2010年10卷111页
Recently, several new endoscopic treatments have been used to treat patients with Barrett's esophagus with high grade dysplasia. This systematic review aimed to determine the safety and effectiveness of these treatments compared with esophagectomy.

335. Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma.

作者: Yanming Zhou.;Yanfang Zhao.;Bin Li.;Donghui Xu.;Zhengfeng Yin.;Feng Xie.;Jiamei Yang.
来源: BMC Gastroenterol. 2010年10卷78页
There is no clear consensus on the better therapy [radiofrequency ablation (RFA) versus hepatic resection (HR)] for small hepatocellular carcinoma (HCC) eligible for surgical treatments. This study is a meta-analysis of the available evidence.

336. Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses.

作者: Gloria Woo.;George Tomlinson.;Yasunori Nishikawa.;Matthew Kowgier.;Morris Sherman.;David K H Wong.;Ba Pham.;Wendy J Ungar.;Thomas R Einarson.;E Jenny Heathcote.;Murray Krahn.
来源: Gastroenterology. 2010年139卷4期1218-29页
The relative efficacies of licensed antiviral therapies for treatment-naive chronic hepatitis B (CHB) infection in randomized controlled trials have not been determined. We evaluated the relative efficacies of the first 12 months of CHB treatments.

337. Moxibustion for ulcerative colitis: a systematic review and meta-analysis.

作者: Dong-Hyo Lee.;Jong-In Kim.;Myeong Soo Lee.;Tae-Young Choi.;Sun-Mi Choi.;Edzard Ernst.
来源: BMC Gastroenterol. 2010年10卷36页
Complementary and alternative medicine (CAM) is increasingly used for treatment of inflammatory bowel disease (IBD). Acupuncture-type treatments are among the most popular options. Several studies have reported that moxibustion is effective in ulcerative colitis (UC). The objective of this review was to assess the clinical evidence for or against moxibustion as a treatment for UC.

338. Plastic or metal stents for benign extrahepatic biliary strictures: a systematic review.

作者: Petra G A van Boeckel.;Frank P Vleggaar.;Peter D Siersema.
来源: BMC Gastroenterol. 2009年9卷96页
Benign biliary strictures may be a consequence of surgical procedures, chronic pancreatitis or iatrogenic injuries to the ampulla. Stents are increasingly being used for this indication, however it is not completely clear which stent type should be preferred.

339. Manganese in parenteral nutrition: who, when, and why should we supplement?

作者: Gil Hardy.
来源: Gastroenterology. 2009年137卷5 Suppl期S29-35页
Micronutrient requirements are not fully understood. Parenteral nutrition (PN) usually contains the trace element (TE) manganese (Mn) from fixed-concentration TE supplements. Multiple TE formulations may not be optimal in pediatric and home PN. Moreover, most PN products contain Mn as a ubiquitous contaminant. Excessive Mn can lead to Parkinson-like symptoms resulting from hypermanganesemia. A survey of 40 Australasian hospitals that contributed data on 108 patients to the annual home PN register and a systematic review of the literature were conducted to establish the scope of the potential problem of Mn toxicity in PN patients. Exposure to Mn doses 5-6 times current daily requirements, together with the TE contamination that is reported in PN products, can lead to neurotoxicity. Whole-blood levels are more accurate for monitoring and correlate well with signal intensity of magnetic resonance imaging. Current TE formulations restrict prescribing options. The regulatory mechanisms of Mn homeostasis are bypassed via the parenteral route so elimination via the hepatobiliary system is impaired, resulting in tissue or brain accumulation. Published dosage recommendations may be excessive and official guidelines require revision. Variability in clinical practices necessitates that individual TE additives are more widely available and multiple TE products reformulated. More frequent monitoring for any brain accumulation is recommended. The scarcity of PN-associated Mn deficiency, plus the growing evidence for Mn toxicity, leads to the conclusion that it is unnecessary for Mn to be prescribed routinely for pediatric or long-term PN patients.

340. Systematic review and meta-analysis on the adverse events of rimonabant treatment: considerations for its potential use in hepatology.

作者: Norberto C Chavez-Tapia.;Felix I Tellez-Avila.;Giorgio Bedogni.;Lory S Crocè.;Flora Masutti.;Claudio Tiribelli.
来源: BMC Gastroenterol. 2009年9卷75页
The cannabinoid-1 receptor blockers have been proposed in the management of obesity and obesity-related liver diseases (fatty liver as NAFLD or NASH). Due to increasing number of patients to be potentially treated and the need to assess the advantage of this treatment in terms of risk/benefit, we analyze the side events reported during the treatment with rimonabant by a systematic review and meta-analysis of all randomized controlled studies.
共有 367 条符合本次的查询结果, 用时 8.108832 秒